The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...
The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC ...
Health and Human Services Secretary Robert F. Kennedy Jr. said Thursday’s deal was the biggest of the pharmaceutical deals ...
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...
Everyday Health on MSN
White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...
The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.
Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...
The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.
A White House guest collapsed behind President Trump during an Oval Office press conference, leading to an abrupt pause in ...
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an ...
The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback